FDA Inspection 1129002 — Tulex Pharmaceuticals Inc.
The FDA completed an inspection of Tulex Pharmaceuticals Inc. on August 14, 2020 in Cranbury, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 14, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Cranbury, NJ (United States)